Trials / Completed
CompletedNCT00439686
Study of ZIO-201 in Advanced Sarcoma
A Phase IB/IIA Study of the Saftey and Activity of Intravenous Isophosporamide Mustard (ZIO-201) in Patients With Advanced Sarcoma
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Alaunos Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced sarcoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ZIO-201 | ZIO-201 given for 3 consecutive days to be repeated every 21 days for up to 6 months |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2008-06-01
- Completion
- 2013-12-01
- First posted
- 2007-02-26
- Last updated
- 2014-01-31
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00439686. Inclusion in this directory is not an endorsement.